- Supported exchanges /
- PINK /
- MLPH.PINK
Molecular Pharmacology (USA) Ltd (MLPH PINK) stock market data APIs
Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical distributors, and through collaborative dealings with companies in the United States and Europe. It also has an agreement with Dermatology Development Corporation to develop and market a range of therapeutic, cosmetic, and cosmecutical products based on the ThermaLIFE product range and its active ingredient. The company is based in Perth, Australia. Molecular Pharmacology (USA) Limited is a subsidiary of PharmaNet Group Limited.
Molecular Pharmacology (USA) Ltd Financial Data Overview
0.0001 | |
0.0001 | |
- | |
0.0001 | |
0.0001 | |
0.0001-0.005 | |
99 955 | |
1 000 M | |
0 | |
-0.0003 | |
53.946 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Molecular Pharmacology (USA) Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -98 105
- Earnings Per Share 0
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Molecular Pharmacology (USA) Ltd Earnings via APIs
- Latest Release 2014-09-30
- EPS/Forecast NaN
Get Molecular Pharmacology (USA) Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: